News

May 21 (Reuters) - The Novo Nordisk Foundation has pledged up to DKK 380 million ($57.76 million) to the World Health Organization (WHO) to expand its tie-up with the United Nations agency for another four years, the philanthropic body said on Wednesday. WHO said on Tuesday it had secured over $170 million in new commitments from multiple countries and organizations, but did not disclose the amount contributed by the foundation, which owns a controlling stake in drugmaker Novo Nordisk (NOVOb.CO), opens new tab. The pledge comes at a time when the WHO faces a major funding shortfall with the planned withdrawal of the United States, its largest donor. WHO plays a unique role in the global health ecosystem, providing normative guidance, monitoring diseases, building country capacity for resilient health systems and supporting learning and evidence," said Mads Krogsgaard Thomsen, CEO of the foundation."